quinoxalines has been researched along with Anochlesia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bundgaard, C; Christoffersen, CT; Jørgensen, M; Rasmussen, LK; Redrobe, JP | 1 |
| da-Silva, CA; Del Bel, EA; Echeverry, MB; Ferreira, FR; Salgado, ML | 1 |
| Schmidt, WJ; Zadow, B | 1 |
| Boldry, RC; Chase, TN; Engber, TM; Papa, SM | 1 |
| Dixon, AK; Gull, P; Hoyer, D; Jaton, AL; Markstein, R; McAllister, K; Rüdeberg, C; Urwyler, S | 1 |
| Breithecker, K; Koch, M; Kratzer, U; Kretschmer, BD | 1 |
| Ikonomidou, C; Sieklucka, M; Turski, WA; Urbańska, E | 1 |
7 other study(ies) available for quinoxalines and Anochlesia
| Article | Year |
|---|---|
Characterisation of Lu AF33241: A novel, brain-penetrant, dual inhibitor of phosphodiesterase (PDE) 2A and PDE10A.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Blood-Brain Barrier; Capillary Permeability; Catalepsy; Cognition; Cyclic Nucleotide Phosphodiesterases, Type 2; Exploratory Behavior; Humans; Male; Motor Activity; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Quinoxalines; Rats, Sprague-Dawley; Rats, Wistar; Recognition, Psychology; Triazoles | 2015 |
Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice.
Topics: Animals; Arginine; Behavior, Animal; Catalepsy; Corpus Striatum; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Indazoles; Injections, Intraventricular; Male; Methylene Blue; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase; Time Factors | 2007 |
The AMPA antagonists NBQX and GYKI 52466 do not counteract neuroleptic-induced catalepsy.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Drug Interactions; Ergolines; Haloperidol; Levodopa; Male; Pilot Projects; Quinoxalines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1994 |
Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
Topics: Animals; Benzazepines; Catalepsy; Dizocilpine Maleate; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Motor Activity; Quinoxalines; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Salicylamides | 1993 |
SDZ PSD 958, a novel D1 receptor antagonist with potential limbic selectivity.
Topics: Acetylcholine; Adenylyl Cyclases; Animals; Apomorphine; Basal Ganglia Diseases; Catalepsy; Cattle; Dopamine Antagonists; Humans; In Vitro Techniques; Limbic System; Male; Mice; Motor Activity; Prolactin; Quinoxalines; Radioligand Assay; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Dopamine D1; Retina; Sympathectomy, Chemical | 1996 |
ACEA 1021, a glycine site antagonist with minor psychotomimetic and amnestic effects in rats.
Topics: Amnesia; Animals; Antimetabolites; Behavior, Animal; Catalepsy; Cycloserine; Excitatory Amino Acid Antagonists; Exploratory Behavior; Hallucinogens; Male; Maze Learning; Motor Activity; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Reflex, Startle | 1997 |
Aminooxyacetic acid produces excitotoxic lesions in the rat striatum.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Aminooxyacetic Acid; Animals; Behavior, Animal; Catalepsy; Caudate Nucleus; Corpus Striatum; Female; Glutamate Decarboxylase; Kynurenic Acid; Male; Microinjections; Microscopy, Electron; Quinoxalines; Rats; Rats, Inbred Strains | 1991 |